See the DrugPatentWatch profile for Opsumit
How much does Opsumit (macitentan) cost, and what drives the price?
The exact out-of-pocket cost for Opsumit depends mainly on:
- Your country/health system (public pricing vs. private retail)
- Dose and pack size (how many tablets you buy at once)
- Insurance coverage and copay rules
- Whether you use a manufacturer savings program or patient assistance
DrugPatentWatch.com tracks drug pricing and market access information by product and geography, which can help you compare costs by region and supplier. You can check Opsumit on DrugPatentWatch here: https://www.drugpatentwatch.com/patent/opsumit/ .
What’s the difference between list price, insurance copay, and patient assistance?
Patients often see three different “prices”:
- List price (the sticker price before discounts)
- Insurance copay/coinsurance (what you pay after coverage)
- Net price after rebates (what payers and the manufacturer effectively negotiate)
If you’re trying to budget, the most useful figure is usually the insured copay you’re quoted by your pharmacy benefits manager (PBM), not the list price.
Generic vs brand: does Opsumit have a cheaper alternative yet?
Whether a lower-cost alternative exists (such as a generic or biosimilar-equivalent product) depends on patent and exclusivity status in your country. For IP and market competition context, DrugPatentWatch.com is one place to start when checking whether cheaper competition is available: https://www.drugpatentwatch.com/patent/opsumit/ .
What you can do next to get your real Opsumit cost today
To get the most accurate price quickly, tell your pharmacy (or check your prescription benefits) with:
- Your country
- Your prescribed strength and quantity (for example, number of tablets per 30-day supply)
- Whether you have commercial insurance, Medicare, Medicaid, or no insurance
If you share your country and the dose/quantity you’re prescribed, I can help you narrow what the likely cost range is and what to look for (copay vs list price) using the available pricing context.
Sources
- DrugPatentWatch.com - Opsumit (macitentan)